Chemotherapy for advanced hormone refractory prostate cancer-Reference-Cited by-同舟云学术

Chemotherapy for advanced hormone refractory prostate cancer

Published:1999-12 Issue:6 Volume:54 Page:30-35
ISSN:0090-4295
Container-title:Urology
language:en
Short-container-title:Urology

Author:

Petrylak Daniel P

Publisher

Elsevier BV

Subject

Urology

Reference32 articles.

1. Landis SH, Murray T, Boldin S, and Wingo PA. Cancer statistics, 1999. CA 49: 8–32, 1999.

2. Cytotoxic chemotherapy for advanced hormone resistant prostate cancer;Yagoda;Cancer,1993

3. Expression of bcl-2 oncoprotein and p53 protein accumulation in bone marrow metastases of androgen independent prostate cancer;McDonnel;J Urol,1997

4. Overexpression of bcl-2 protects prostate cancer cells from apoptosis in vitro and confers resistance to androgen depletion in vivo;Raffo;Cancer Res,1995

5. Combination adriamycin and suramin induces apoptosis in bcl-2 expressing prostate carcinoma cells;Tu;Cancer Lett,1995

Cited by 88 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Structural insights into the mechanism of resistance to bicalutamide by the clinical mutations in androgen receptor in chemo-treatment resistant prostate cancer;Journal of Biomolecular Structure and Dynamics;2023-05-05

2. EGFR‑associated pathways involved in traditional Chinese medicine (TCM)‑1‑induced cell growth inhibition, autophagy and apoptosis in prostate cancer;Molecular Medicine Reports;2018-03-28

3. Traditional Chinese Medicine CFF-1 induced cell growth inhibition, autophagy, and apoptosis via inhibiting EGFR-related pathways in prostate cancer;Cancer Medicine;2018-03-13

4. Enhancement of cisplatin cytotoxicity by Retigeric acid B involves blocking DNA repair and activating DR5 in prostate cancer cells;Oncology Letters;2017-12-20

5. A co-delivery nanosystem of chemotherapeutics and DNAzyme overcomes cancer drug resistance and metastasis;Nano Futures;2017-12-13